These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 12148780)

  • 1. Synthesis of a 2-arylsulphonylated tryptophan: the antibacterial activity of bovine lactoferricin peptides containing Trp(2-Pmc).
    Haug BE; Andersen J; Rekdal O; Svendsen JS
    J Pept Sci; 2002 Jul; 8(7):307-13. PubMed ID: 12148780
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Simple parameterization of non-proteinogenic amino acids for QSAR of antibacterial peptides.
    Lejon T; Svendsen JS; Haug BE
    J Pept Sci; 2002 Jul; 8(7):302-6. PubMed ID: 12148779
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of tryptophan in the antibacterial activity of a 15-residue bovine lactoferricin peptide.
    Haug BE; Svendsen JS
    J Pept Sci; 2001 Apr; 7(4):190-6. PubMed ID: 11354462
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of charge and lipophilicity on the antibacterial activity of undecapeptides derived from bovine lactoferricin.
    Strøm MB; Rekdal O; Svendsen JS
    J Pept Sci; 2002 Jan; 8(1):36-43. PubMed ID: 11831560
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibacterial activity of 15-residue lactoferricin derivatives.
    Strøm MB; Rekdal O; Svendsen JS
    J Pept Res; 2000 Nov; 56(5):265-74. PubMed ID: 11095180
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prediction of antibiotic activity and synthesis of new pentadecapeptides based on lactoferricins.
    Lejon T; Stiberg T; Strøm MB; Svendsen JS
    J Pept Sci; 2004 Jun; 10(6):329-35. PubMed ID: 15214437
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bulky aromatic amino acids increase the antibacterial activity of 15-residue bovine lactoferricin derivatives.
    Haug BE; Skar ML; Svendsen JS
    J Pept Sci; 2001 Aug; 7(8):425-32. PubMed ID: 11548058
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bactericidal effect of bovine lactoferrin, LFcin, LFampin and LFchimera on antibiotic-resistant Staphylococcus aureus and Escherichia coli.
    Flores-Villaseñor H; Canizalez-Román A; Reyes-Lopez M; Nazmi K; de la Garza M; Zazueta-Beltrán J; León-Sicairos N; Bolscher JG
    Biometals; 2010 Jun; 23(3):569-78. PubMed ID: 20195887
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Variation in antimicrobial activity of lactoferricin-derived peptides explained by structure modelling.
    Farnaud S; Patel A; Odell EW; Evans RW
    FEMS Microbiol Lett; 2004 Sep; 238(1):221-6. PubMed ID: 15336425
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthetic porcine lactoferricin with a 20-residue peptide exhibits antimicrobial activity against Escherichia coli, Staphylococcus aureus, and Candida albicans.
    Chen HL; Yen CC; Lu CY; Yu CH; Chen CM
    J Agric Food Chem; 2006 May; 54(9):3277-82. PubMed ID: 16637685
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interactions of lactoferricin-derived peptides with LPS and antimicrobial activity.
    Farnaud S; Spiller C; Moriarty LC; Patel A; Gant V; Odell EW; Evans RW
    FEMS Microbiol Lett; 2004 Apr; 233(2):193-9. PubMed ID: 15063486
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bactericidal kinetics of 3 lactoferricins against Staphylococcus aureus and Escherichia coli.
    Ulvatne H; Vorland LH
    Scand J Infect Dis; 2001; 33(7):507-11. PubMed ID: 11515760
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural studies and model membrane interactions of two peptides derived from bovine lactoferricin.
    Nguyen LT; Schibli DJ; Vogel HJ
    J Pept Sci; 2005 Jul; 11(7):379-89. PubMed ID: 15635665
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Post-antibiotic effect of the antimicrobial peptide lactoferricin on Escherichia coli and Staphylococcus aureus.
    Haukland HH; Vorland LH
    J Antimicrob Chemother; 2001 Oct; 48(4):569-71. PubMed ID: 11581240
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antimicrobial activity of short arginine- and tryptophan-rich peptides.
    Strøm MB; Rekdal O; Svendsen JS
    J Pept Sci; 2002 Aug; 8(8):431-7. PubMed ID: 12212806
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibacterial activity of short hydrophobic and basic-rich peptides.
    Chen PW; Shyu CL; Mao FC
    Am J Vet Res; 2003 Sep; 64(9):1088-92. PubMed ID: 13677384
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased antibacterial activity of 15-residue murine lactoferricin derivatives.
    Strøm MB; Rekdal O; Stensen W; Svendsen JS
    J Pept Res; 2001 Feb; 57(2):127-39. PubMed ID: 11168896
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lactoferricin of bovine origin is more active than lactoferricins of human, murine and caprine origin.
    Vorland LH; Ulvatne H; Andersen J; Haukland H; Rekdal O; Svendsen JS; Gutteberg TJ
    Scand J Infect Dis; 1998; 30(5):513-7. PubMed ID: 10066056
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of shortening lactoferrin derived peptides against tumour cells, bacteria and normal human cells.
    Yang N; Strøm MB; Mekonnen SM; Svendsen JS; Rekdal O
    J Pept Sci; 2004 Jan; 10(1):37-46. PubMed ID: 14959890
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Homology similarity analysis of sequences of lactoferricin and its derivatives.
    Nakai S; Chan JC; Li-Chan EC; Dou J; Ogawa M
    J Agric Food Chem; 2003 Feb; 51(5):1215-23. PubMed ID: 12590458
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.